BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Depomed, Inc. 

1360 O'Brien Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-462-5900 Fax: 650-462-9993


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Delivery





 Company News
Depomed, Inc. (DEPO) Announces Pricing Of Upsized $300 Million Convertible Senior Notes Due 2021 9/5/2014 1:01:31 PM
Depomed, Inc. (DEPO) Summary Judgment Motion Granted In Suit Against FDA Seeking Orphan Drug Exclusivity For Gralise® (Gabapentin) 9/5/2014 12:56:26 PM
Depomed, Inc. (DEPO) Announces Offering Of $230 Million Convertible Senior Notes Due 2021 9/3/2014 4:15:51 PM
Depomed, Inc. (DEPO) To Present At Morgan Stanley 2014 Global Healthcare Conference 8/26/2014 8:58:29 AM
Depomed, Inc. (DEPO) Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024 8/19/2014 10:39:25 AM
Depomed, Inc. (DEPO) Reports Second Quarter 2014 Financial Results 8/7/2014 8:46:46 AM
Depomed, Inc. (DEPO) Announces Appointment of R. Scott Shively As Chief Commercial Officer 8/5/2014 7:06:44 AM
Depomed, Inc. (DEPO) To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 7/28/2014 8:31:27 AM
Depomed, Inc. (DEPO) Announces District Court Order In ANDA Litigation 7/18/2014 9:16:50 AM
Depomed, Inc. (DEPO) Announces Appointment Of Srinivas G. Rao, MD, PhD, As Chief Medical Officer 7/16/2014 11:04:34 AM
12345678910...